The future of metabolomics in ELIXIR [version 2; referees: 2 approved, 1 approved with reservations]

Metabolomics, the youngest of the major omics technologies, is supported by an active community of researchers and infrastructure developers across Europe. To coordinate and focus efforts around infrastructure building for metabolomics within Europe, a workshop on the “Future of metabolomics in ELIX...

Full description

Bibliographic Details
Main Authors: Merlijn van Rijswijk, Charlie Beirnaert, Christophe Caron, Marta Cascante, Victoria Dominguez, Warwick B. Dunn, Timothy M. D. Ebbels, Franck Giacomoni, Alejandra Gonzalez-Beltran, Thomas Hankemeier, Kenneth Haug, Jose L. Izquierdo-Garcia, Rafael C. Jimenez, Fabien Jourdan, Namrata Kale, Maria I. Klapa, Oliver Kohlbacher, Kairi Koort, Kim Kultima, Gildas Le Corguillé, Pablo Moreno, Nicholas K. Moschonas, Steffen Neumann, Claire O’Donovan, Martin Reczko, Philippe Rocca-Serra, Antonio Rosato, Reza M. Salek, Susanna-Assunta Sansone, Venkata Satagopam, Daniel Schober, Ruth Shimmo, Rachel A. Spicer, Ola Spjuth, Etienne A. Thévenot, Mark R. Viant, Ralf J. M. Weber, Egon L. Willighagen, Gianluigi Zanetti, Christoph Steinbeck
Format: Article
Language:English
Published: F1000 Research Ltd 2017-10-01
Series:F1000Research
Subjects:
Online Access:https://f1000research.com/articles/6-1649/v2
_version_ 1818277089858551808
author Merlijn van Rijswijk
Charlie Beirnaert
Christophe Caron
Marta Cascante
Victoria Dominguez
Warwick B. Dunn
Timothy M. D. Ebbels
Franck Giacomoni
Alejandra Gonzalez-Beltran
Thomas Hankemeier
Kenneth Haug
Jose L. Izquierdo-Garcia
Rafael C. Jimenez
Fabien Jourdan
Namrata Kale
Maria I. Klapa
Oliver Kohlbacher
Kairi Koort
Kim Kultima
Gildas Le Corguillé
Pablo Moreno
Nicholas K. Moschonas
Steffen Neumann
Claire O’Donovan
Martin Reczko
Philippe Rocca-Serra
Antonio Rosato
Reza M. Salek
Susanna-Assunta Sansone
Venkata Satagopam
Daniel Schober
Ruth Shimmo
Rachel A. Spicer
Ola Spjuth
Etienne A. Thévenot
Mark R. Viant
Ralf J. M. Weber
Egon L. Willighagen
Gianluigi Zanetti
Christoph Steinbeck
author_facet Merlijn van Rijswijk
Charlie Beirnaert
Christophe Caron
Marta Cascante
Victoria Dominguez
Warwick B. Dunn
Timothy M. D. Ebbels
Franck Giacomoni
Alejandra Gonzalez-Beltran
Thomas Hankemeier
Kenneth Haug
Jose L. Izquierdo-Garcia
Rafael C. Jimenez
Fabien Jourdan
Namrata Kale
Maria I. Klapa
Oliver Kohlbacher
Kairi Koort
Kim Kultima
Gildas Le Corguillé
Pablo Moreno
Nicholas K. Moschonas
Steffen Neumann
Claire O’Donovan
Martin Reczko
Philippe Rocca-Serra
Antonio Rosato
Reza M. Salek
Susanna-Assunta Sansone
Venkata Satagopam
Daniel Schober
Ruth Shimmo
Rachel A. Spicer
Ola Spjuth
Etienne A. Thévenot
Mark R. Viant
Ralf J. M. Weber
Egon L. Willighagen
Gianluigi Zanetti
Christoph Steinbeck
author_sort Merlijn van Rijswijk
collection DOAJ
description Metabolomics, the youngest of the major omics technologies, is supported by an active community of researchers and infrastructure developers across Europe. To coordinate and focus efforts around infrastructure building for metabolomics within Europe, a workshop on the “Future of metabolomics in ELIXIR” was organised at Frankfurt Airport in Germany. This one-day strategic workshop involved representatives of ELIXIR Nodes, members of the PhenoMeNal consortium developing an e-infrastructure that supports workflow-based metabolomics analysis pipelines, and experts from the international metabolomics community. The workshop established metabolite identification as the critical area, where a maximal impact of computational metabolomics and data management on other fields could be achieved. In particular, the existing four ELIXIR Use Cases, where the metabolomics community - both industry and academia - would benefit most, and which could be exhaustively mapped onto the current five ELIXIR Platforms were discussed. This opinion article is a call for support for a new ELIXIR metabolomics Use Case, which aligns with and complements the existing and planned ELIXIR Platforms and Use Cases.
first_indexed 2024-12-12T22:56:00Z
format Article
id doaj.art-c94085c689b54380a553c8703294e419
institution Directory Open Access Journal
issn 2046-1402
language English
last_indexed 2024-12-12T22:56:00Z
publishDate 2017-10-01
publisher F1000 Research Ltd
record_format Article
series F1000Research
spelling doaj.art-c94085c689b54380a553c8703294e4192022-12-22T00:08:56ZengF1000 Research LtdF1000Research2046-14022017-10-01610.12688/f1000research.12342.213993The future of metabolomics in ELIXIR [version 2; referees: 2 approved, 1 approved with reservations]Merlijn van Rijswijk0Charlie Beirnaert1Christophe Caron2Marta Cascante3Victoria Dominguez4Warwick B. Dunn5Timothy M. D. Ebbels6Franck Giacomoni7Alejandra Gonzalez-Beltran8Thomas Hankemeier9Kenneth Haug10Jose L. Izquierdo-Garcia11Rafael C. Jimenez12Fabien Jourdan13Namrata Kale14Maria I. Klapa15Oliver Kohlbacher16Kairi Koort17Kim Kultima18Gildas Le Corguillé19Pablo Moreno20Nicholas K. Moschonas21Steffen Neumann22Claire O’Donovan23Martin Reczko24Philippe Rocca-Serra25Antonio Rosato26Reza M. Salek27Susanna-Assunta Sansone28Venkata Satagopam29Daniel Schober30Ruth Shimmo31Rachel A. Spicer32Ola Spjuth33Etienne A. Thévenot34Mark R. Viant35Ralf J. M. Weber36Egon L. Willighagen37Gianluigi Zanetti38Christoph Steinbeck39ELIXIR-NL, Dutch Techcentre for Life Sciences, Utrecht, 3503 RM, NetherlandsADReM, Department of Mathematics and Computer Science, University of Antwerp, Antwerp, 2020, BelgiumELIXIR-FR, French Institute of Bioinformatics, Gif-sur-Yvette, F-91198, FranceDepartment of Biochemistry and Molecular Biomedicine, Faculty of Biology, Universitat de Barcelona, Barcelona, 08028, SpainELIXIR-FR, French Institute of Bioinformatics, Gif-sur-Yvette, F-91198, FranceSchool of Biosciences, Phenome Centre Birmingham and Birmingham Metabolomics Training Centre, University of Birmingham, Birmingham, B15 2TT, UKComputational and Systems Medicine, Department of Surgery and Cancer, Imperial College London, London, SW7 2AZ, UKINRA, UNH, Human Nutrition Unit, PFEM, Metabolism Exploration Platform, MetaboHUB-Clermont, Clermont Auvergne University, Clermont-Ferrand, F-63000, FranceOxford e-Research Centre, Engineering Science Department, University of Oxford, Oxford, OX1 3QG, UKNetherlands Metabolomics Center, Leiden, 2333 CC, NetherlandsEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, CB10 1SD, UKCentro Nacional Investigaciones Cardiovasculares, Madrid, 28029, SpainELIXIR Hub, Cambridge, CB10 1SD, UKToxalim, UMR 1331, Université de Toulouse, Toulouse, F-31300, FranceEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, CB10 1SD, UKMetabolic Engineering and Systems Biology Laboratory, Institute of Chemical Engineering Sciences, Foundation for Research & Technology – Hellas (FORTH/ICE-HT), Patras, GR-26504, GreeceBiomolecular Interactions, Max Planck Institute for Developmental Biology, Tübingen, 72076, GermanyThe Centre of Excellence in Neural and Behavioural Sciences, Tallinn, Tallinn, 10120, EstoniaDepartment of Medical Sciences, Uppsala University, Uppsala, 752 36, SwedenUPMC, CNRS, FR2424, ABiMS, Station Biologique, Roscoff, F-29680, FranceEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, CB10 1SD, UKDepartment of General Biology, School of Medicine, University of Patras, Patras, GR-26504, GreeceDepartment of Stress and Developmental Biology, Leibniz Institute of Plant Biochemistry, Halle, 06120, GermanyEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, CB10 1SD, UKBSRC “Alexander Fleming”, Athens, GR-16672, GreeceOxford e-Research Centre, Engineering Science Department, University of Oxford, Oxford, OX1 3QG, UKMagnetic Resonance Center, Interuniversity Consortium for Magnetic Resonance on MetalloProteins, University of Florence, Florence, 50121, ItalyEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, CB10 1SD, UKOxford e-Research Centre, Engineering Science Department, University of Oxford, Oxford, OX1 3QG, UKLuxembourg Centre For Systems Biomedicine (LCSB), University of Luxembourg, Belvaux, L-4367, LuxembourgDepartment of Stress and Developmental Biology, Leibniz Institute of Plant Biochemistry, Halle, 06120, GermanyThe Centre of Excellence in Neural and Behavioural Sciences, Tallinn, Tallinn, 10120, EstoniaEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, CB10 1SD, UKDepartment of Pharmaceutical Biosciences, Uppsala University, Uppsala, 752 36, SwedenCEA, LIST, Laboratory for Data Analysis and Systems’ Intelligence, MetaboHUB, Gif-sur-Yvette, F-91191, FranceSchool of Biosciences, Phenome Centre Birmingham and Birmingham Metabolomics Training Centre, University of Birmingham, Birmingham, B15 2TT, UKSchool of Biosciences, Phenome Centre Birmingham and Birmingham Metabolomics Training Centre, University of Birmingham, Birmingham, B15 2TT, UKDepartment of Bioinformatics - BiGCaT, NUTRIM, Maastricht University, Maastricht, NL-6200, NetherlandsCRS4, Data Intensive Computing Group, Ed.1 POLARIS, Pula, 09010, ItalyFriedrich-Schiller-University, Jena, 07743, GermanyMetabolomics, the youngest of the major omics technologies, is supported by an active community of researchers and infrastructure developers across Europe. To coordinate and focus efforts around infrastructure building for metabolomics within Europe, a workshop on the “Future of metabolomics in ELIXIR” was organised at Frankfurt Airport in Germany. This one-day strategic workshop involved representatives of ELIXIR Nodes, members of the PhenoMeNal consortium developing an e-infrastructure that supports workflow-based metabolomics analysis pipelines, and experts from the international metabolomics community. The workshop established metabolite identification as the critical area, where a maximal impact of computational metabolomics and data management on other fields could be achieved. In particular, the existing four ELIXIR Use Cases, where the metabolomics community - both industry and academia - would benefit most, and which could be exhaustively mapped onto the current five ELIXIR Platforms were discussed. This opinion article is a call for support for a new ELIXIR metabolomics Use Case, which aligns with and complements the existing and planned ELIXIR Platforms and Use Cases.https://f1000research.com/articles/6-1649/v2Chemical Biology of the Cell
spellingShingle Merlijn van Rijswijk
Charlie Beirnaert
Christophe Caron
Marta Cascante
Victoria Dominguez
Warwick B. Dunn
Timothy M. D. Ebbels
Franck Giacomoni
Alejandra Gonzalez-Beltran
Thomas Hankemeier
Kenneth Haug
Jose L. Izquierdo-Garcia
Rafael C. Jimenez
Fabien Jourdan
Namrata Kale
Maria I. Klapa
Oliver Kohlbacher
Kairi Koort
Kim Kultima
Gildas Le Corguillé
Pablo Moreno
Nicholas K. Moschonas
Steffen Neumann
Claire O’Donovan
Martin Reczko
Philippe Rocca-Serra
Antonio Rosato
Reza M. Salek
Susanna-Assunta Sansone
Venkata Satagopam
Daniel Schober
Ruth Shimmo
Rachel A. Spicer
Ola Spjuth
Etienne A. Thévenot
Mark R. Viant
Ralf J. M. Weber
Egon L. Willighagen
Gianluigi Zanetti
Christoph Steinbeck
The future of metabolomics in ELIXIR [version 2; referees: 2 approved, 1 approved with reservations]
F1000Research
Chemical Biology of the Cell
title The future of metabolomics in ELIXIR [version 2; referees: 2 approved, 1 approved with reservations]
title_full The future of metabolomics in ELIXIR [version 2; referees: 2 approved, 1 approved with reservations]
title_fullStr The future of metabolomics in ELIXIR [version 2; referees: 2 approved, 1 approved with reservations]
title_full_unstemmed The future of metabolomics in ELIXIR [version 2; referees: 2 approved, 1 approved with reservations]
title_short The future of metabolomics in ELIXIR [version 2; referees: 2 approved, 1 approved with reservations]
title_sort future of metabolomics in elixir version 2 referees 2 approved 1 approved with reservations
topic Chemical Biology of the Cell
url https://f1000research.com/articles/6-1649/v2
work_keys_str_mv AT merlijnvanrijswijk thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT charliebeirnaert thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT christophecaron thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT martacascante thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT victoriadominguez thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT warwickbdunn thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT timothymdebbels thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT franckgiacomoni thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT alejandragonzalezbeltran thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT thomashankemeier thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT kennethhaug thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT joselizquierdogarcia thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT rafaelcjimenez thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT fabienjourdan thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT namratakale thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT mariaiklapa thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT oliverkohlbacher thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT kairikoort thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT kimkultima thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT gildaslecorguille thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT pablomoreno thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT nicholaskmoschonas thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT steffenneumann thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT claireodonovan thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT martinreczko thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT philipperoccaserra thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT antoniorosato thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT rezamsalek thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT susannaassuntasansone thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT venkatasatagopam thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT danielschober thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT ruthshimmo thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT rachelaspicer thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT olaspjuth thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT etienneathevenot thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT markrviant thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT ralfjmweber thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT egonlwillighagen thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT gianluigizanetti thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT christophsteinbeck thefutureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT merlijnvanrijswijk futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT charliebeirnaert futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT christophecaron futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT martacascante futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT victoriadominguez futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT warwickbdunn futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT timothymdebbels futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT franckgiacomoni futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT alejandragonzalezbeltran futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT thomashankemeier futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT kennethhaug futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT joselizquierdogarcia futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT rafaelcjimenez futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT fabienjourdan futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT namratakale futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT mariaiklapa futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT oliverkohlbacher futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT kairikoort futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT kimkultima futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT gildaslecorguille futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT pablomoreno futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT nicholaskmoschonas futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT steffenneumann futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT claireodonovan futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT martinreczko futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT philipperoccaserra futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT antoniorosato futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT rezamsalek futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT susannaassuntasansone futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT venkatasatagopam futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT danielschober futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT ruthshimmo futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT rachelaspicer futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT olaspjuth futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT etienneathevenot futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT markrviant futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT ralfjmweber futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT egonlwillighagen futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT gianluigizanetti futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations
AT christophsteinbeck futureofmetabolomicsinelixirversion2referees2approved1approvedwithreservations